Carisoprodol

卡立普多

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCarisoprodol
Drug Alias NameCarisoprodolum卡来梯肌安宁卡利普多异丙安宁 +[9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsLow Back PainMusculoskeletal Pain
Global Approved IndicationsMusculoskeletal Pain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1959/04/09
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMeda Ab
China Registration ClassN/A

Develop Information

Active CompaniesMylan Speciality Lp
Inactive CompaniesMeda Ab
Active IndicationsMusculoskeletal Pain
Inactive IndicationsLow Back Pain

Other Information

ATC CodeM03BA02